Oncotarget
Subscribe in ParasocialFree on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed. Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed. Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/
Also on
Recent episodes
- International Tumor Board Explores Personalized Treatment Strategies for Colon Cancer Without Measurable Disease
- International Tumor Board Explores Personalized Treatment Options for Glioblastoma With MDM2 and EGFR Amplifications
- Molecular Tumor Board Maps Precision Treatment Options for a Woman With Multiple Primary Cancers
- Pan-Cancer Analysis Identifies Buckwheat-Derived Compound as Potential AKT1 Drug-Design Candidate
- Epigenetic Silencing of TRAIL-R2 Is Linked to Aggressive Features in Breast Cancer
- Gut Microbiome Emerges as a Potential Partner in Precision Cancer Therapy
- DHHC3 Helps Melanoma Tumors Evade Antitumor Immunity
- Commentary Calls for Consistent Evaluation of Potential Links Between COVID-19, Vaccination and Cancer
- Restoring MHC-I Expression Could Strengthen Immune Responses Against CNS Cancers
- Therapeutic HPV Vaccine PepCan Tested for Preventing Head and Neck Cancer Recurrence